ROCLANDA gtt opht fl 2.5 ml
7680690430016
CH-69043
S01EE51
11.09.0.
1 / 3
google
Details
- Product number
- 6904301
- CPT
- -
- Packaging group
- 2,5
- Unit
- ml
- Composition
- netarsudilum 0.2 mg ut netarsudili dimesilas, latanoprostum 0.05 mg, mannitolum, acidum boricum, benzalkonii chloridum 0.2 mg, natrii hydroxidum ad pH, aqua ad iniectabile ad solutionem pro 1 ml.
Articles (1)
Roclanda, collyre en solution
Augentropfen
2,5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.2 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.05 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.2 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Santen SA
1202 Genève
Authorization information
- Swissmedic authorization number
- 69043
- Drug name
- Roclanda, collyre en solution
- Galenic form
- AUL
- ATC Code
- S01EE51
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/10/2023
- Authorization expiration date
- 02/10/2028
- IT number
- 11.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ROCLANDA gtt opht fl 2.5 ml
- Description (DE)
- ROCLANDA Gtt Opht Fl 2.5 ml
- Market launch
- 03/10/2023
- Narcotic (BTM)
- No